In the News
Nanotechnology World: Synthetic Vaccines – Addressing the “One Bug One Drug” Phenomenon
21 June 2018
CNBC news interview with Emergex Vaccines CEO, Professor Thomas Rademacher
14 May 2018
BioWorld: Thinking on a global scale, Emergex Vaccines using lessons from Ebola outbreak
3 May 2018
LONDON – The lessons of the Ebola epidemic have come together with a series of scientific advances, and expertise acquired over a lifetime in biotech, to inspire a novel vaccine technology that is designed to provide genus-wide protection against viral infections.
